Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tandem Diabetes Care, Inc. - Common Stock
(NQ:
TNDM
)
16.78
-0.30 (-1.76%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tandem Diabetes Care, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025
July 01, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
July 01, 2025
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process.
Via
Investor's Business Daily
1 Stock Under $50 with Solid Fundamentals and 2 to Ignore
June 23, 2025
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...
Via
StockStory
Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
June 20, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Earnings Scheduled For April 30, 2025
April 30, 2025
Via
Benzinga
1 Growth Stock with All-Star Potential and 2 to Keep Off Your Radar
June 18, 2025
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...
Via
StockStory
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
June 17, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END
Via
FinancialNewsMedia
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
June 17, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued
June 10, 2025
The agreement is to develop and commercialize integrated diabetes solutions that combine Abbott's future dual glucose-ketone sensor with San Diego, California- based Tandem's innovative insulin...
Via
Stocktwits
Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor
June 10, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
June 02, 2025
Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.
Via
Benzinga
Reflecting On Healthcare Technology Stocks’ Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM)
May 26, 2025
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Tandem Diabetes (NASDAQ:TNDM) and its peers.
Via
StockStory
Where Tandem Diabetes Care Stands With Analysts
May 22, 2025
Via
Benzinga
Fortune Brands, Whirlpool, Align Technology, Tandem Diabetes, and STAAR Surgical Shares Plummet, What You Need To Know
May 21, 2025
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that...
Via
StockStory
Topics
Bonds
Stocks
1 Momentum Stock with Impressive Fundamentals and 2 to Turn Down
May 16, 2025
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to new product launches, positive news, or even a dedicated social media...
Via
StockStory
TNDM Q1 Earnings Call: Product Expansion and Channel Initiatives Drive Growth Against Margin Pressures
May 14, 2025
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) announced better-than-expected revenue in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full...
Via
StockStory
3 of Wall Street’s Favorite Stocks in Dangerous Territory
May 12, 2025
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...
Via
StockStory
Tandem Diabetes Care Announces Upcoming Conference Presentations
May 06, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Tandem Diabetes Care Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)
May 01, 2025
Via
Benzinga
Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars
April 30, 2025
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full...
Via
StockStory
Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars
April 30, 2025
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects...
Via
StockStory
Tandem Diabetes Care Announces First Quarter 2025 Financial Results
April 30, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
Insights into Tandem Diabetes Care's Upcoming Earnings
April 29, 2025
Via
Benzinga
Tandem Diabetes (TNDM) Q1 Earnings Report Preview: What To Look For
April 29, 2025
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting results tomorrow after the bell. Here’s what you need to know.
Via
StockStory
Topics
Artificial Intelligence
1 Volatile Stock Worth Your Attention and 2 to Keep Off Your Radar
April 22, 2025
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...
Via
StockStory
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
April 15, 2025
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
Via
StockStory
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
April 12, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
World Trade
Forecasting The Future: 9 Analyst Projections For Tandem Diabetes Care
April 10, 2025
Via
Benzinga
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
April 04, 2025
Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies...
Via
Benzinga
Topics
Government
World Trade
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
April 03, 2025
From
Tandem Diabetes Care, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.